Bioextrax AB (publ) (STO:BIOEX)
Sweden · Delayed Price · Currency is SEK 2.340
-0.040 (-1.68%)
Sep 3, 2026, 3:46 PM CET
Bioextrax AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.39 | 3.93 | 17.27 | 13.4 | 27.53 | 8.98 |
Cash & Short-Term Investments | 7.39 | 3.93 | 17.27 | 13.4 | 27.53 | 8.98 |
Cash Growth | -31.53% | -77.23% | 28.87% | -51.33% | 206.69% | 337.54% |
Accounts Receivable | 0.01 | 0.03 | - | - | 0.03 | 0.12 |
Other Receivables | 0.36 | 0.79 | 0.73 | 0.71 | 1.27 | 0.79 |
Receivables | 0.37 | 0.81 | 0.73 | 0.71 | 1.3 | 0.91 |
Prepaid Expenses | 1.08 | 0.29 | 0.29 | 0.29 | 0.34 | 0.22 |
Other Current Assets | - | 0.5 | 0.91 | 0.36 | 1.23 | 1.31 |
Total Current Assets | 8.84 | 5.54 | 19.2 | 14.76 | 30.4 | 11.42 |
Property, Plant & Equipment | 5.65 | 5.84 | 6.82 | 7.76 | 7.49 | 1.22 |
Other Long-Term Assets | - | 13.34 | 2.98 | - | 0.03 | - |
Total Assets | 14.49 | 24.73 | 29 | 22.52 | 37.92 | 12.64 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.39 | 1.18 | 1.53 | 1.33 | 3.56 | 2.22 |
Accrued Expenses | 1.42 | 0.91 | 0.84 | 0.44 | 0.98 | 1.04 |
Current Income Taxes Payable | - | 0.08 | 0.1 | 0.14 | 0.13 | 0.06 |
Current Unearned Revenue | - | - | - | -0.59 | 0.89 | 1.41 |
Other Current Liabilities | 0.7 | 1.35 | 0.47 | 0.67 | 0.6 | 0.41 |
Total Current Liabilities | 2.51 | 3.51 | 2.94 | 1.98 | 6.15 | 5.14 |
Total Liabilities | 2.51 | 3.51 | 2.94 | 1.98 | 6.15 | 5.14 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.4 | 2.02 | 1.97 | 1.47 | 1.28 | 0.74 |
Additional Paid-In Capital | - | 12.14 | 22.32 | 9.86 | 41.73 | 15.96 |
Retained Earnings | 9.58 | 6.68 | 1.73 | 9.21 | -11.24 | -9.2 |
Comprehensive Income & Other | - | 0.38 | 0.05 | - | - | 0 |
Shareholders' Equity | 11.98 | 21.22 | 26.06 | 20.54 | 31.77 | 7.5 |
Total Liabilities & Equity | 14.49 | 24.73 | 29 | 22.52 | 37.92 | 12.64 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 7.39 | 3.93 | 17.27 | 13.4 | 27.53 | 8.98 |
Net Cash Growth | -31.53% | -77.23% | 28.87% | -51.33% | 206.69% | 337.54% |
Net Cash Per Share | 0.17 | 0.10 | 0.52 | 0.51 | 1.63 | 0.67 |
Filing Date Shares Outstanding | 47.6 | 40.03 | 39.12 | 29.23 | 25.46 | 14.75 |
Total Common Shares Outstanding | 47.6 | 40.03 | 39.12 | 29.23 | 25.46 | 14.75 |
Working Capital | 6.33 | 2.03 | 16.26 | 12.78 | 24.25 | 6.28 |
Book Value Per Share | 0.25 | 0.53 | 0.67 | 0.70 | 1.25 | 0.51 |
Tangible Book Value | 11.98 | 21.22 | 26.06 | 20.54 | 31.77 | 7.5 |
Tangible Book Value Per Share | 0.25 | 0.53 | 0.67 | 0.70 | 1.25 | 0.51 |
Machinery | - | 10.14 | 9.99 | 9.77 | 8.64 | 1.9 |